Skip to Content

Tag: Continuous Glucose Monitoring


Dexcom enters VC space

February 15, 2021HME News Staff

SAN DIEGO – Dexcom has launched Dexcom Ventures to identify and invest in opportunities to supplement growth in its core business of continuous glucose monitoring and advance the development of adjacent technologies.  Dexcom Ventures, led by Dexcom veteran Steve Pacelli, will be focused on investment opportunities in sensing technology, data analytics, remote patient monitoring and population health, broadening the company’s commitment to advancing better outcomes in health care.  “Driven...

Continuous Glucose Monitoring, Dexcom, Diabetes, venture capital

Read Full Articlered right arrow icon


CMS publishes jam-packed proposed rule

October 27, 2020HME News Staff

WASHINGTON - CMS seeks to continue paying higher payment amounts to suppliers in non-competitive bidding areas as part of a DMEPOS proposed rule that it published on Tuesday afternoon.The agency also seeks to: permanently exempt manual wheelchairs and accessories from the bid program; classify all continuous glucose monitors, not just therapeutic CGMs, as DME and establish payment amounts for them and their related supplies and accessories; and expand the classification of external infusion pumps...

Competitive Bidding, Continuous Glucose Monitoring, DMEPOS Proposed Rule, External Infusion Pumps, Manual wheelchair accessories

Read Full Articlered right arrow icon

Also Noted

Medtronic offers pandemic assistance

May 7, 2020HME News Staff

DUBLIN - Medtronic has expanded its Medtronic Assurance program for U.S. customers who lose their jobs and health insurance due to COVID-19. Current eligible customers can receive a three-month supply of sensors, infusion sets and reservoirs at no cost. “Knowing that concerns around continuity of therapy are at the very top of mind for people living with diabetes, Medtronic wants to ensure during this stressful and challenging time that we can be there for our customers when they need it most,”...

Continuous Glucose Monitoring, Diabetes, Medtronic

Read Full Articlered right arrow icon

Specialty Providers

Walgreens and CGMs: Providers emphasize billing, service expertise

November 22, 2019Theresa Flaherty, Managing Editor

DEERFIELD, Ill. - Walgreens has made a push into the continuous glucose monitoring market, but HME providers warn that providing diabetes care is a different animal than filling prescriptions.The onerous paperwork, alone, would seem to be a huge obstacle for retail pharmacies, says Tim Cady, president of Carlsbad, Calif.-based Advanced Diabetes Supplies, a large distributor of Dexcom products. “The records that are required and the way you need to interpret the local coverage determination...

Continuous Glucose Monitoring, Diabetes, walgreens

Read Full Articlered right arrow icon

Also Noted

Second CGM receives Medicare approval

January 9, 2018HME News Staff

ABBOTT PARK, Ill. - The FreeStyle Libre System is the second continuous glucose monitoring system approved for Medicare coverage. The Abbott-manufactured system requires no user calibration, reading glucose levels via a sensor worn on the upper arm. Users simply wave a reader over the sensor to get a reading. CMS in early 2017 approved certain CGMs as DME as long as they are approved by the Food and Drug Administration for use in place of a blood glucose monitor for making treatment decisions. The...

Continuous Glucose Monitoring, Diabetes, FreeStyle Libre, Medicare coverage

Read Full Articlered right arrow icon

Specialty Providers

CMS greenlights CGMs for coverage

January 17, 2017HME News Staff

WASHINGTON - CMS classified “therapeutic” continuous glucose monitoring systems as durable medical equipment in a Jan. 12 ruling.CMS says CGMs are considered therapeutic and meet the definition of DME if:. They are approved by the FDA for use in place of a blood glucose monitor for making diabetes treatment decisions (for example, changes in diet and insulin dosage);. They are generally not useful to the individual in the absence of an illness or injury;. They are appropriate for use...

Continuous Glucose Monitoring, Diabetes, Medicare coverage, Technology

Read Full Articlered right arrow icon

Specialty Providers

FDA expands approval for CGM system

December 23, 2016HME News Staff

SAN DIEGO - Dexcom has received expanded approval from the U.S. Food and Drug Administration for the G5 mobile continuous glucose monitoring system.This is the first FDA-approved continuous glucose monitoring system that can be used to make diabetes treatment decisions without confirmation from a traditional fingerstick test. The system was previously approved to complement, not replace, fingerstick testing for diabetes treatment decisions.“This may allow some patients to manage their disease...

Continuous Glucose Monitoring, Dexcom, FDA

Read Full Articlered right arrow icon